Rancangan Program Terapi Artikulasi Bagi Anak Cerebral Palsy Kelas Iv Sd Di Slb Ypac (Yayasan Pembina Anak Cacat) Makassar
Jiptek : Jurnal Pengabdian Ilmu Pengetahuan dan Teknologi · 2024
DOI: 10.62527/jiptek.2.1.13 ↗Kurz gefasst
Fachartikel in der Zeitschrift Jiptek : Jurnal Pengabdian Ilmu Pengetahuan dan Teknologi, 2024. Verfasst von Wizerti Ariastuti Saleh und 3 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-SA 4.0).
Abstract (Originalsprache)
Communication barriers in children with Cerebral Palsy affect their language development. This is evident from the difficulty children have in pronouncing certain consonants, making it hard for others to understand their speech. An approach tailored to the needs of each child is crucial. Articulation therapy plays a role in helping children improve their speaking abilities by training the muscles involved in sound production. This therapy must be specifically designed to meet the needs of each child. A comprehensive approach and support from family and the environment are essential for the therapy's success
Zitieren
APA
Saleh, W. A., Likoelangi, I. A., Mentari, L., & Karambe, A. R. (2024). Rancangan Program Terapi Artikulasi Bagi Anak Cerebral Palsy Kelas Iv Sd Di Slb Ypac (Yayasan Pembina Anak Cacat) Makassar. Jiptek : Jurnal Pengabdian Ilmu Pengetahuan dan Teknologi. https://doi.org/10.62527/jiptek.2.1.13
Vancouver
Saleh WA, Likoelangi IA, Mentari L, Karambe AR. Rancangan Program Terapi Artikulasi Bagi Anak Cerebral Palsy Kelas Iv Sd Di Slb Ypac (Yayasan Pembina Anak Cacat) Makassar. Jiptek : Jurnal Pengabdian Ilmu Pengetahuan dan Teknologi. 2024. doi:10.62527/jiptek.2.1.13
BibTeX
@article{Saleh2024,
author = {Saleh, Wizerti Ariastuti and Likoelangi, Ivana Ameylia and Mentari, Lidia and Karambe, Astria Rosselin},
title = {Rancangan Program Terapi Artikulasi Bagi Anak Cerebral Palsy Kelas Iv Sd Di Slb Ypac (Yayasan Pembina Anak Cacat) Makassar},
journal = {Jiptek : Jurnal Pengabdian Ilmu Pengetahuan dan Teknologi},
year = {2024},
doi = {10.62527/jiptek.2.1.13}
}
EUVIMED